Inhibition of the high affinity myo-inositol transport system: A common mechanism of action of antibipolar drugs?

Neuropsychopharmacology

Volumn 21, Issue 4, 1999, Pages 519-529

  Lubrich, Beate ^a   Van Calker, Dietrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Affective disorders; Mood stabilizer; SMIT

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; INOSITOL; LITHIUM; MESSENGER RNA; VALPROIC ACID;

AFFECTIVE NEUROSIS; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CELL CULTURE; DOWN REGULATION; DRUG MECHANISM; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; AMITRIPTYLINE; ANIMALS; ANTIMANIC AGENTS; ASTROCYTES; BIOLOGICAL TRANSPORT; BRAIN; CARBAMAZEPINE; CARRIER PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; INOSITOL; LITHIUM; MEMBRANE PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; SYMPORTERS; TIME FACTORS; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0032864255     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00037-8     Document Type: Article

References (41)

1. Allison J.H., Steward M.A. Reduced brain inositol in lithium-treated rats. Nature New Biol. 233:1971;267-268.
2. Altshuler L.L., Post R.M., Leverich G.S., Mikalauskas K., Rosoff A., Ackerman L. Antidepressant-induced mania and cycle acceleration. A controversy revisited Am J Physiol. 152:1995;1130-1138.
3. Ayane M., Nielsen P., Kohler G. Cloning and sequencing of mouse ribosomal S12 cDNA. Nucleic Acids Res. 17:1989;6722.
4. Baltuch G.H., Dooley N.P., Rostworowski K.M., Villemure J.G., Yong V.W. Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation. J Neurooncol. 24(3):1995;241-250.
5. Batty J.H., Michi A., Fennel M., Downes C.P. The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells. Biochem J. 294:1993;49-55.
6. Berridge M.J., Downes C.P., Hanley M.R. Neural and development actions of lithium. A unifying hypothesis Cell. 59:1989;411-419.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:1976;248-254.
8. Chen G., Manji H.K., Hawver D.B., Wright C.B., Potter W.Z. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem. 63:1994;2361-2364.
9. Chen G., Pan B., Hawver D.B., Wright C.B., Potter W.Z., Manji H.K. Attenuation of cyclic AMP production by carbamazepine. J Neurochem. 67(5):1996;2079-2086.
10. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanat-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
11. Cohen DM, Wasserman JC, Gullans SR (1991): Immediate early gene and HSP70 expression in hyperosmotic stress in MDCK cells. Am Phys Soc C 261:594-601.
12. Couldwell W.T., Antel J.P., Yong V.W. Protein kinase C activity correlates with the growth rate of malignant gliomas. Part II. Effects of glioma mitogens and modulators of protein kinase C Neurosurgery. 31(4):1992;717-724.
13. Dermietzel R., Spray D.C. Gap Junctions and Glia [Special issue]. GLIA. 24:1998;1-150.
14. Divish M.M., Sheftel G., Boyle A., Kalasapudi V.P., Papolos D.F., Lachman H.M. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate. Model for its antimanic action J Neurosci Res. 28:1991;40-48.
15. Duffy S., MacVicar B.A. Adrenergic calcium signaling in astrocyte networks within the hippocampal slice. J Neurosci. 15:1995;5535-5550.
16. Elphick M., Taghavi Z., Powell T., Godfrey P.P. Alteration of inositol phospholipid metabolism in rat cortex by lithium but not carbamazepine. Eur J Pharmacol. 156:1988;411-414.
17. Gani D., Downes C.P., Batty J., Bramham J. Lithium and myo-inositol homeostasis. Biochim Biophys Acta. 1177:1993;253-269.
18. Gebicke-Haerter P.J., Bauer J., Schobert A., Northoff H. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci. 9:1989;183-194.
19. Glanville N.T., Byers H.V., Cook M.W., Spence F.B., Palmer C. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal anf glial origin. Biochim Biophys Acta. 1004:1989;169-179.
20. Goodwin F.K., Jamison K.R. Manic-Depressive Illness. 1990;Oxford University Press, New York.
21. Hamprecht B.H., Löffler F. Primary glial cultures as a model for studying hormone action. Methods Enzymol. 109:1985;341-345.
22. Handler S.H., Kwon H.M. Regulation of renal cell organic osmolyte transport by tonicity. Am Phys Soc. 265:1993;1449-1455.
23. Hansson E. Regional heterogenity among astrocytes in the central nervous system. Neurochem Int. 16:1990;237-245.
24. Jope R.S., Williams M.B. Lithium and brain signal transduction systems. Biochem Pharmacol. 47:1994;429-441.
25. Lee S.H., Kim W.T., Cornell-Bell A.H., Sontheimer H. Astrocytes exhibit regional specifity in gap-junction coupling. GLIA. 11:1994;315-325.
26. Lenox R.H., McNamara R.K., Watterson J.M., Watson D.G. Myristoylated alanine-rich C kinase substrate (MARCKS). A molecular target for the therapeutic action of mood stabilizers in the brain? J Clin Psychiatry. 57(suppl 13):1996;23-31.
27. Lubrich B., Kofman O., Agam G., Berger M., Belmaker R.H., van Calker D. Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus. Mol Psychiatry. 2:1997;407-412.
28. Manji H.K., Lenox R.H. Lomg-term action of lithium. A role for transcriptional and posttranscriptional factors regulated by protein kinase C Synapse. 16:1994;11-28.
29. Manji H.K., Chen G., Hsiao J.K., Risby E.D., Masana M.I., Potter W.Z. Regulation of signal transduction pathways by mood stabilizing agents. Implications for the delayed onset of therapeutic efficacy J Clin Psychiat. 57(suppl 13):1996;34-46.
30. Manji H.K., Potter W.Z., Lenox R.A. Signal transduction pathways. Molecular target for lithium's action. Arch Gen Psychiatry. 52:1995;531-543.
31. McCarthy M.F. Up-regulation of intracellular signalling pathways may play a central role in hypertension; atherogenesis, insulin resistance and cancer promotion-the "PKC syndrome" Med Hypertheses. 46(3):1996;191-221.
32. McDermott E.E., Logan S.D. Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus. Br J Pharmacol. 98:1989;581-589.
33. McMillan M.K., Thai L., Hong J.-S., O'Callaghan J.P., Pennypacker K.R. Brain injury in a dish. A model for reactive gliosis Trends NeuroSci. 17:1994;138-142.
34. Mork A., Geisler A., Hollund P. Effects of lithium on second messenger systems in brain. Pharmacol Toxicol. 71:1992;4-17.
35. Patishi Y., Lubrich B., Berger M., van Calker D., Belmaker R.H. Differential uptake of myo-inositol in vivo into rat brain areas. Eur Neuropsychopharmacol. 6:1996;73-75.
36. Preston A.S., Yamauchi A., Kwon H.M., Hander J.S. Activators of protein kinase A and of protein kinase C inhibit MDCK cell myo-inositol and betaine uptake. J Am Soc Nephrol. 6:1995;1559-1564.
37. Shao Y., Porter J.T., McCarthy K.D. Neuroligand receptor heterogenity among astroglia. Perspect Dev Neurobiol. 2:1994;205-215.
38. van Calker D., Steber R., Klotz K.N., Greil W. Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol. 206:1991;285-290.
39. Verkhratsky A., Orkand R.K., Kettenmann H. Glial calcium. Homeostasis and signaling function Physiol Rev. 78:1998;99-141.
40. Wiesinger H. Myo-inositol transport in mouse astroglia-rich primary cultures. J Neurochem. 56:1991;1698-1704.
41. Wolfson M., Hertz E., Belmaker R.H., Hertz L. Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool size in glia like cells by different mechanisms. Brain Res. 787:1998;34-40.